Ibrutinib-induced cardiomyopathy

The use of ibrutinib for the treatment of chronic lymphocytic leukemia (CLL) and other hematologic malignancies is blooming. Atrial fibrillation is a known side effect of ibrutinib but cardiomyopathy was not reported previously. We present an 88-year-old man with CLL who was admitted to the hospital...

Full description

Saved in:
Bibliographic Details
Main Authors: Htay Htay Kyi (Author), Yazan Zayed (Author), Samer Al Hadidi (Author)
Format: Book
Published: Greater Baltimore Medical Center, 2019-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available